Literature DB >> 17971937

[Variations of hepatitis B virus infection epidemic pattern after long-term HBV vaccine immunization].

Li-Ping Shen1, Jin-Ye Yang, Zhao-Jun Mo, Rong-Cheng Li, Yan-Ping Li, Zeng-Liang Wei, Yong-Hui Dong, Kai-Jiao Zhou, Shao-Chao Wei, Kong-Xiong Fang, Tao Yu, Wen-Ying Zhang, Yong Zhang, Sheng-Li Bi.   

Abstract

OBJECTIVE: To study the epidemic pattern and trend of HBV infection in the area where the people had been immunized by HBV vaccine for 20 years.
METHODS: The whole sampling method was applied in combination with cross-sectional investigation. Blood samples were taken from every member of families. Markers of HBV infection were determined by using solid-phase radioimmunoassay (SPRIA).
RESULTS: (1) The average HBsAg positive rate was 7.5%. The positive rate of markers for HBV infection of 0-19 years old subjects were lower than those of > or = 20 years old subjects. (2) The positive rate of HBsAg of 0-19 years old subjects in 1985 was higher than that in 2005. The anti-HBs positive rate in 1985 stemmed to be higher with age. It was 12.4% in 1- age group to 53.8% in >60 years age group. While the result of 2005 showed that the anti-HBs positive rate of 0-19 years old subjects dropped with age. The anti-HBc positive rate in 1985 also tended to be higher with age. But the result of 2005 showed that the rate of 0-19 years old subjects was just 1.4% to 16.8%.
CONCLUSION: The epidemic patterns of HBV infection have had significant variations in the target population. HBV vaccine immunization has obtained excellent efficacy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971937

Source DB:  PubMed          Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi        ISSN: 1003-9279


  2 in total

1.  Reply letter regarding seroconversion of hepatitis B surface antigen in a successful long-term immune cohort.

Authors:  Zhigang Zheng; Qing-Lei Zeng; Yi-Hua Zhou
Journal:  Hum Vaccin Immunother       Date:  2021-04-14       Impact factor: 3.452

2.  Seroconversion of hepatitis B surface antigen among those with previously successful immune response in Southern China.

Authors:  Zhigang Zheng; Guojian Li; Fuhui Liao; Lujuan Zhang; Xueyan Wang; Zhongliao Fang; Qinyan Chen; Huabin Liu; Liping Hu
Journal:  Hum Vaccin Immunother       Date:  2020-09-22       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.